Multi-Center Clinical Database of Infants for the Investigation of Early Nutrition Biomarkers
Launched by BYHEART · Sep 9, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The first Cohort (Cohort 1) goals of the registry include: to compile a clinical database of children who were fed in SS-101-18 by breastfeeding, commercial formula, or ByHeart formula; to investigate any difference in demographics, growth, development, medical diagnoses, and outcomes between the feeding groups, and in particular to compare ByHeart formula-fed infants against commercial formula-fed infants, and referenced against breastfed infants.
The second Cohort (Cohort 2) goals of the registry include: to compile a clinical database of children who were fed by breastfeeding or commerc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria Cohort 1:
- • Active participation in SS-101-18 through Visit 9
- • Provision of signed and dated informed consent form (ICF) by parent or legally authorized representative (LAR)
- • Stated willingness to comply with all study procedures by parent or LAR.
- Exclusion Criteria Cohort 1:
- • Did not participate in SS-101-18
- • Participated in SS-101-18 that withdrew from the study for any reason prior to Visit 9
- • Anything that in the opinion of the Investigator is likely to interfere with participation in the registry.
- Inclusion Criteria Cohort 2:
- • Be less than 120 days old at the time of enrollment
- • Provision of signed and dated informed consent form (ICF) by parent or legally authorized representative (LAR)
- • Stated willingness to comply with all study procedures by parent or LAR.
- Exclusion Criteria Cohort 2:
- • Participation in SS-101-18
- • Anything that, in the opinion of the Investigator, is likely to interfere with participation in the registry.
- • In the opinion of the investigator, has a diagnosed medical condition or genetic abnormality known to impact growth or development.
About Byheart
ByHeart is a pioneering nutrition company dedicated to transforming infant formula with a focus on quality, safety, and innovation. Committed to advancing infant health, ByHeart employs rigorous scientific research and clinical trials to develop products that meet the highest standards of nutritional excellence. With a mission to provide parents with trusted, evidence-based options, ByHeart leverages cutting-edge technology and a team of experts to ensure that their formulas are not only effective but also aligned with the latest advancements in pediatric nutrition. Through its commitment to transparency and consumer education, ByHeart aims to empower families in making informed choices for their children's health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingsport, Tennessee, United States
Jonesboro, Arkansas, United States
Birmingham, Alabama, United States
Tampa, Florida, United States
Charleston, South Carolina, United States
Summerville, South Carolina, United States
Tucson, Arizona, United States
Cincinnati, Ohio, United States
Birmingham, Alabama, United States
Tucson, Arizona, United States
Jonesboro, Arkansas, United States
Tampa, Florida, United States
Cincinnati, Ohio, United States
Charleston, South Carolina, United States
Summerville, South Carolina, United States
Kingsport, Tennessee, United States
Idaho Falls, Idaho, United States
Layton, Utah, United States
Tuscan, Arizona, United States
Patients applied
Trial Officials
Devon Kuehn, M.D.
Study Director
ByHeart
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials